Skyrizi

Pharma

AbbVie plots $10B US outlay as pharma tariff threat looms

With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.

Fraiser Kansteiner Apr 25, 2025 11:52am

Novo’s Wegovy, J&J’s Tremfya led March TV ad spending totals

Apr 7, 2025 11:21am

Digestion digestive system stomach ibd crohns disease ulcerative colitis

J&J's Tremfya picks up key FDA nod in Crohn's disease

Mar 20, 2025 7:56pm

AbbVie’s Rinvoq, Skyrizi regain TV ad spending lead in February

Mar 12, 2025 10:53am

AbbVie's Rob Michael collected $18.5M in '24 CEO debut

Mar 11, 2025 1:11pm

UCB's Bimzelx outpacing AbbVie's Rinvoq, Skyrizi on awareness

Feb 14, 2025 9:20am